Resultats de la cerca - Kazuya Ishiwata

  • Mostrar 1 - 6 resultats de 6
Refinar resultats
  1. 1
    Selenosugars are key and urinary metabolites for selenium excretion within the required to low-toxic range

    Selenosugars are key and urinary metabolites for selenium excretion within the required to low-toxic range per Yayoi Kobayashi, Yasumitsu Ogra, Kazuya Ishiwata, Hiromitsu Takayama, Norio Aimi, Kazuo Suzuki

    Publicat 2002
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Successful sustained engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with severe aplastic anemia

    Successful sustained engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with severe aplastic anemia per Hisashi Yamamoto, Daisuke Kato, Naoyuki Uchida, Kazuya Ishiwata, Hideki Araoka, Shinsuke Takagi, Nobuaki Nakano, Masanori Tsuji, Yuki Asano‐Mori, Naofumi Matsuno, Kazuhiro Masuoka, Koji Izutsu, Atsushi Wake, Akiko Yoneyama, Shigeyoshi Makino, Shuichi Taniguchi

    Publicat 2011
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Mycophenolate and Tacrolimus for Graft-Versus-Host Disease Prophylaxis for Elderly After Cord Blood Transplantation: A Matched Pair Comparison With Tacrolimus Alone

    Mycophenolate and Tacrolimus for Graft-Versus-Host Disease Prophylaxis for Elderly After Cord Blood Transplantation: A Matched Pair Comparison With Tacrolimus Alone per Naoyuki Uchida, Atsushi Wake, Nobuaki Nakano, Kazuya Ishiwata, Shinsuke Takagi, Masanori Tsuji, Hisashi Yamamoto, Daisuke Kato, Naofumi Matsuno, Kazuhiro Masuoka, Hideki Araoka, Yuki Asano‐Mori, Koji Izutsu, Shigeyoshi Makino, Akiko Yoneyama, Shuichi Taniguchi

    Publicat 2011
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    A Novel Reduced-Toxicity Myeloablative Conditioning Regimen Using Full-Dose Busulfan, Fludarabine, and Melphalan for Single Cord Blood Transplantation Provides Durable Engraftment and Remission in Nonremission Myeloid Malignancies

    A Novel Reduced-Toxicity Myeloablative Conditioning Regimen Using Full-Dose Busulfan, Fludarabine, and Melphalan for Single Cord Blood Transplantation Provides Durable Engraftment... per Hisashi Yamamoto, Naoyuki Uchida, Mitsuhiro Yuasa, Kosei Kageyama, Hikari Ota, Daisuke Kaji, Aya Nishida, Kazuya Ishiwata, Shinsuke Takagi, Masanori Tsuji, Yuki Asano‐Mori, Go Yamamoto, Koji Izutsu, Kazuhiro Masuoka, Atsushi Wake, Akiko Yoneyama, Shigeyoshi Makino, Shuichi Taniguchi

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    High incidence of haemophagocytic syndrome following umbilical cord blood transplantation for adults

    High incidence of haemophagocytic syndrome following umbilical cord blood transplantation for adults per Shinsuke Takagi, Kazuhiro Masuoka, Naoyuki Uchida, Kazuya Ishiwata, Hideki Araoka, Masanori Tsuji, Hisashi Yamamoto, Daisuke Kato, Yoshiko Matsuhashi, Eiji Kusumi, Yasunori Ota, Sachiko Seo, Tomoko Matsumura, Naofumi Matsuno, Atsushi Wake, Shigesaburo Miyakoshi, Shigeyoshi Makino, Kenichi Ohashi, Akiko Yoneyama, Shuichi Taniguchi

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Impact of Haplo-Donor Age on Transplant Outcomes: A Comparative Analysis of Haploidentical vs Cord Blood Transplantation

    Impact of Haplo-Donor Age on Transplant Outcomes: A Comparative Analysis of Haploidentical vs Cord Blood Transplantation per Takashi Nagayama, Shin-ichiro Fujiwara, Satoshi Nishiwaki, Fumiya Wada, Naoyuki Uchida, Masatsugu Tanaka, Mamiko Sakata‐Yanagimoto, Makoto Onizuka, Kazuya Ishiwata, Yuta Hasegawa, Shuichi Ota, Noriko Doki, Hirohisa Nakamae, Tetsuya Nishida, Toshiro Kawakita, Masashi Sawa, Masahito Tokunaga, Fumihiko Ishimaru, Takahiro Fukuda, Yoshinobu Kanda, Yoshiko Atsuta, Hideki Nakasone

    Publicat 2025
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: